BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 15528208)

  • 21. Co-regulator recruitment and the mechanism of retinoic acid receptor synergy.
    Germain P; Iyer J; Zechel C; Gronemeyer H
    Nature; 2002 Jan; 415(6868):187-92. PubMed ID: 11805839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retinoid X receptor is a nonsilent major contributor to vitamin D receptor-mediated transcriptional activation.
    Bettoun DJ; Burris TP; Houck KA; Buck DW; Stayrook KR; Khalifa B; Lu J; Chin WW; Nagpal S
    Mol Endocrinol; 2003 Nov; 17(11):2320-8. PubMed ID: 12893883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific structural motifs determine TRAP220 interactions with nuclear hormone receptors.
    Ren Y; Behre E; Ren Z; Zhang J; Wang Q; Fondell JD
    Mol Cell Biol; 2000 Aug; 20(15):5433-46. PubMed ID: 10891484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains.
    Bourguet W; Vivat V; Wurtz JM; Chambon P; Gronemeyer H; Moras D
    Mol Cell; 2000 Feb; 5(2):289-98. PubMed ID: 10882070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Control of retinoic acid receptor heterodimerization by ligand-induced structural transitions. A novel mechanism of action for retinoid antagonists.
    Depoix C; Delmotte MH; Formstecher P; Lefebvre P
    J Biol Chem; 2001 Mar; 276(12):9452-9. PubMed ID: 11254657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of RXR-RAR Heterodimers by RXR- and RAR-Specific Ligands and Their Combinations.
    le Maire A; Teyssier C; Balaguer P; Bourguet W; Germain P
    Cells; 2019 Nov; 8(11):. PubMed ID: 31694317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The isolation and characterization of purified heterocomplexes of recombinant retinoic acid receptor and retinoid X receptor ligand binding domains.
    Tian K; Norris AW; Lin CL; Li E
    Biochemistry; 1997 May; 36(19):5669-76. PubMed ID: 9153406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. H11-H12 loop retinoic acid receptor mutants exhibit distinct trans-activating and trans-repressing activities in the presence of natural or synthetic retinoids.
    Lefebvre B; Mouchon A; Formstecher P; Lefebvre P
    Biochemistry; 1998 Jun; 37(26):9240-9. PubMed ID: 9649304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular cloning of xSRC-3, a novel transcription coactivator from Xenopus, that is related to AIB1, p/CIP, and TIF2.
    Kim HJ; Lee SK; Na SY; Choi HS; Lee JW
    Mol Endocrinol; 1998 Jul; 12(7):1038-47. PubMed ID: 9658407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Asymmetry in the PPARgamma/RXRalpha crystal structure reveals the molecular basis of heterodimerization among nuclear receptors.
    Gampe RT; Montana VG; Lambert MH; Miller AB; Bledsoe RK; Milburn MV; Kliewer SA; Willson TM; Xu HE
    Mol Cell; 2000 Mar; 5(3):545-55. PubMed ID: 10882139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PGC-1 functions as a transcriptional coactivator for the retinoid X receptors.
    Delerive P; Wu Y; Burris TP; Chin WW; Suen CS
    J Biol Chem; 2002 Feb; 277(6):3913-7. PubMed ID: 11714715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of receptor-interacting protein 140 in retinoid receptor activities.
    Lee CH; Wei LN
    J Biol Chem; 1999 Oct; 274(44):31320-6. PubMed ID: 10531331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The retinoid X receptor ligand restores defective signalling by the vitamin D receptor.
    Sánchez-Martínez R; Castillo AI; Steinmeyer A; Aranda A
    EMBO Rep; 2006 Oct; 7(10):1030-4. PubMed ID: 16936639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Separation of retinoid X receptor homo- and heterodimerization functions.
    Vivat-Hannah V; Bourguet W; Gottardis M; Gronemeyer H
    Mol Cell Biol; 2003 Nov; 23(21):7678-88. PubMed ID: 14560013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retinoic acid receptors: structural basis for coregulator interaction and exchange.
    le Maire A; Bourguet W
    Subcell Biochem; 2014; 70():37-54. PubMed ID: 24962880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heterodimers of retinoic acid receptors and thyroid hormone receptors display unique combinatorial regulatory properties.
    Lee S; Privalsky ML
    Mol Endocrinol; 2005 Apr; 19(4):863-78. PubMed ID: 15650024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of ligand-induced heterodimerization and coactivator interaction by the activation function-2 domain of the vitamin D receptor.
    Liu YY; Nguyen C; Peleg S
    Mol Endocrinol; 2000 Nov; 14(11):1776-87. PubMed ID: 11075811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transactivation by retinoid X receptor-peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimers: intermolecular synergy requires only the PPARgamma hormone-dependent activation function.
    Schulman IG; Shao G; Heyman RA
    Mol Cell Biol; 1998 Jun; 18(6):3483-94. PubMed ID: 9584188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular determinants of nuclear receptor-corepressor interaction.
    Perissi V; Staszewski LM; McInerney EM; Kurokawa R; Krones A; Rose DW; Lambert MH; Milburn MV; Glass CK; Rosenfeld MG
    Genes Dev; 1999 Dec; 13(24):3198-208. PubMed ID: 10617569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural basis for autorepression of retinoid X receptor by tetramer formation and the AF-2 helix.
    Gampe RT; Montana VG; Lambert MH; Wisely GB; Milburn MV; Xu HE
    Genes Dev; 2000 Sep; 14(17):2229-41. PubMed ID: 10970886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.